Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Observe Medical ASA: Observe Medical Launches New Website to Strengthen Dialogue with Healthcare Decision-Makers Around Innovative UnoMeter™ Safeti™ Max

OBSRVPress release22.09.2026, 11.00

Oslo, 22 September 2026 - Observe Medical ASA (the "Company" or "Observe Medical") today announces the launch of its new website, designed to create a direct, responsive dialogue with healthcare decision-makers about UnoMeter™ Safeti™ Max, an innovative solution with the potential to deliver clear clinical and health-economic advantages.

The new digital platform provides healthcare leaders, decision-makers, clinicians and other stakeholders with accessible information about UnoMeter™ Safeti™ Max and the rest of the Company's portfolio, its clinical evidence and its contribution to more efficient and sustainable healthcare.

"Healthcare decision-makers need clear, evidence-based information that demonstrates both patient value and the broader impact on healthcare systems," said Jørgen Mann, CEO at Observe Medical. "With our new website, we want to make it easier to engage directly with those responsible for healthcare decisions and have a constructive dialogue about how UnoMeter™ Safeti™ Max can address important clinical and health-economic needs."

For further information, please contact: 

Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.